General Information of Drug (ID: DM4GEUF)

Drug Name
BCX-25 Drug Info
Synonyms BCX-14
Indication
Disease Entry ICD 11 Status REF
Arthritis FA20 Terminated [1]
Cross-matching ID
TTD Drug ID
DM4GEUF

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Discontinued Drug(s)
Drug(s) Targeting Transferase unspecific (TF)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ademetionine DMYQDBO Hepatic fibrosis DB93.0 Approved [3]
Lomeguatrib DMW9MOK Solid tumour/cancer 2A00-2F9Z Discontinued in Phase 2 [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Transferase unspecific (TF) TTX2N1T NOUNIPROTAC Modulator [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004493)
2 CN patent application no. 1096855, Composition produced by treatment and induction of nitrogen mono oxide synthase expressed matter, and use thereof.
3 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2013
4 O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas. Cell Death Dis. 2013 Oct 24;4:e876.